And given the low to nearly non-existence or side effects, and high efficacy, the liklihood of approval is 99%, like NP said a month or so ago.
The 13-15% non-approval rate of BLA submissions is no doubt related to side effects and questionable efficacy.
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-